BiotechTube
Home/Novakand Pharma/Peter Selin
PS

Peter Selin

CEO

Novakand Pharma

Therapeutic Areas

Inflammatory DiseasesOncology

Novakand Pharma Pipeline

DrugIndicationPhase
RugocrixanInflammatory diseases / CancerClinical
FosrugocrixanInflammatory diseases / CancerClinical

Leadership Team at Novakand Pharma

EN
Erik Nerpin
Chairman of the Board
TO
Thomas Olin
Senior Scientific Advisor, Board Member
AG
Anders Gabrielsen
Board Member
View full Novakand Pharma profile